Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TGAN Stock Summary
Top 10 Correlated ETFs
TGAN
In the News
Transphorm to Present at the 26th Annual Needham Growth Conference
GOLETA, Calif.--(BUSINESS WIRE)--Transphorm, Inc. (Nasdaq: TGAN)— a global leader in robust gallium nitride (“GaN”) power semiconductors—today announced that President, Co-founder and CEO of Transphorm, Primit Parikh, Ph.D., and Chief Financial Officer, Cameron McAulay, will provide a business update and company presentation at the 26th Annual Needham Growth Conference on January 19th, 2024 at 3:45 p.m Eastern Time. 26th Annual Needham Growth Conference Location: Virtual Date: Friday, January 1.
Transphorm, Inc. (TGAN) Q2 2024 Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q2 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants David Hanover – Investor Relations Primit Parikh – Co-Founder, President and Chief Executive Officer Cameron McAulay – Chief Financial Officer Conference Call Participants David Williams – The Benchmark Company Ethan Widell – B. Riley Ananda Baruah – Loop Capital Aaron Martin – AIGH Investment Partners Operator Thank you for standing by, and welcome to Transphorm's Second Quarter Fiscal 2024 Earnings Conference Call.
Transphorm to Announce Fiscal 2024 Second Quarter Results and Business Update Call on November 9th at 5:00pm ET
GOLETA, Calif.--(BUSINESS WIRE)--Transphorm, Inc. (NASDAQ: TGAN)— a global leader in GaN, the future of next generation power systems, announced today it will host a conference call and webcast on Monday November 9, 2023 at 5:00 p.m. ET to discuss the Company's financial results for the 2024 fiscal second quarter. Conference Call and Webcast Information Event: Transphorm Fiscal 2024 Second Quarter Financial Results Date: Thursday, November 9, 2023 Time: 5:00 p.m. Eastern Time Webcast: https://e.
Transphorm, Inc. (TGAN) Q1 2024 Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q1 2024 Earnings Conference Call August 14, 2023 5:00 PM ET Company Participants David Hanover - IR Primit Parikh - CEO, President & Co-Founder Cameron McAulay - CFO Conference Call Participants David Williams - Benchmark Company Ananda Baruah - Loop Capital Craig Ellis - B. Riley Tore Svanberg - Stifel Operator Thank you for standing by, and welcome to Transphorm's First Quarter Fiscal 2024 Conference Call.
Transphorm to Present at the Canaccord Genuity 43rd Annual Growth Conference
GOLETA, Calif.--(BUSINESS WIRE)--Transphorm, Inc. (NASDAQ: TGAN)—a global leader in GaN, the future of next generation power systems, announced today that Primit Parikh, CEO, President and Co-Founder, will participate in the Canaccord Genuity 43rd Annual Growth Conference, at the InterContinental Boston Hotel, taking place August 7-10, 2023. Dr. Parikh will be available during the conference to meet with participating investors. Canaccord Genuity 43rd Annual Growth Conference Location: InterCon.
Transphorm, Inc. (TGAN) Q4 2023 Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q4 2023 Earnings Call Transcript June 27, 2023 5:00 PM ET Company Participants David Hanover - Investor Relations Primit Parikh - CEO President and Co-Founder Cameron McAulay - CFO Conference Call Participants David Williams - Benchmark Company Craig Ellis - B. Riley Richard Shannon - Craig-Hallum Capital Group Operator Thank you for standing by, and welcome to the Transphorm's Fourth Quarter and Full Year Fiscal 2023 Earnings Call.
Transphorm, Inc. (TGAN) Reports Q4 Loss, Misses Revenue Estimates
Transphorm, Inc. (TGAN) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.08 per share a year ago.
Transphorm to Present at Upcoming December Investor Conference
GOLETA, Calif.--( BUSINESS WIRE )--Transphorm, Inc. (NASDAQ: TGAN)—a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today President & COO, Primit Parikh, Ph.D., will present at the Oppenheimer 5G Summit: The Revolution Continues, which is being held virtually on December 13, 2022. Management is scheduled to host a live fireside chat and will be available throughout the day to meet with participating investors.
Transphorm, Inc. (TGAN) Q2 2023 Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q2 2023 Results Conference Call November 9, 2022 5:00 PM ET Company Participants Jack Perkins - KCSA Strategic Communications Mario Rivas - CEO Primit Parikh - Co-Founder, President and COO Cameron McAulay - CFO Conference Call Participants David Williams - Benchmark Company Craig Ellis - B. Riley Ananda Baruah - Loop Capital Sam Peterman - Craig-Hallum Orin Hirschman - AIGH Partners Operator Good day, and thank you for standing by.
Transphorm, Inc. (TGAN) Reports Q2 Loss, Tops Revenue Estimates
Transphorm, Inc. (TGAN) delivered earnings and revenue surprises of 18.18% and 1.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
TGAN Financial details
TGAN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2018-06-30 | 2019-12-31 | 2020-12-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.34 | 0.36 | 0.52 | 0.29 | |
Net income per share | 0 | -0.53 | -0.71 | -0.23 | -0.56 | |
Operating cash flow per share | 0 | -0.35 | -0.44 | -0.43 | -0.47 | |
Free cash flow per share | 0 | -0.36 | -0.45 | -0.44 | -0.59 | |
Cash per share | 0 | 0.08 | 0.46 | 0.73 | 0.28 | |
Book value per share | 0 | -3.48 | -0.63 | 0.68 | 0.35 | |
Tangible book value per share | 0 | -3.55 | -0.7 | 0.64 | 0.32 | |
Share holders equity per share | 0 | -3.48 | -0.63 | 0.68 | 0.35 | |
Interest debt per share | 0 | 1.21 | 1.14 | 0.28 | 0.28 | |
Market cap | 0 | 175.68M | 130.13M | 325.62M | 224.35M | |
Enterprise value | -4.5K | 214.43M | 150.98M | 304.36M | 223.89M | |
P/E ratio | 0 | -9.42 | -5.8 | -30.79 | -7.08 | |
Price to sales ratio | 0 | 14.72 | 11.44 | 13.54 | 13.59 | |
POCF ratio | 0 | -14.29 | -9.22 | -16.62 | -8.46 | |
PFCF ratio | 0 | -14.06 | -9.18 | -16.02 | -6.71 | |
P/B Ratio | 0 | -1.44 | -6.55 | 10.38 | 11.44 | |
PTB ratio | 0 | -1.44 | -6.55 | 10.38 | 11.44 | |
EV to sales | 0 | 17.97 | 13.28 | 12.66 | 13.56 | |
Enterprise value over EBITDA | 0.1 | -16.11 | -9.25 | -35.39 | -7.9 | |
EV to operating cash flow | 0.1 | -17.45 | -10.7 | -15.54 | -8.45 | |
EV to free cash flow | 0.1 | -17.16 | -10.65 | -14.97 | -6.69 | |
Earnings yield | 0 | -0.11 | -0.17 | -0.03 | -0.14 | |
Free cash flow yield | 0 | -0.07 | -0.11 | -0.06 | -0.15 | |
Debt to equity | 0 | -0.34 | -1.79 | 0.39 | 0.77 | |
Debt to assets | 0 | 4.06 | 1.6 | 0.25 | 0.34 | |
Net debt to EBITDA | 0.1 | -2.91 | -1.28 | 2.47 | 0.02 | |
Current ratio | 0.07 | 0.26 | 0.68 | 8.45 | 1.4 | |
Interest coverage | 0 | -15.72 | -17.63 | -12.49 | -39.42 | |
Income quality | 0 | 0.8 | 0.79 | 1.91 | 0.87 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.55 | 0.91 | 0.47 | 0.83 | |
Research and developement to revenue | 0 | 0.68 | 0.49 | 0.28 | 0.54 | |
Intangibles to total assets | 0 | 0.26 | 0.11 | 0.04 | 0.03 | |
Capex to operating cash flow | 0 | 0.02 | 0 | 0.04 | 0.26 | |
Capex to revenue | 0 | -0.02 | -0.01 | -0.03 | -0.42 | |
Capex to depreciation | 0 | -0.17 | -0.07 | -0.88 | -4.52 | |
Stock based compensation to revenue | 0 | 0.05 | 0.13 | 0.11 | 0.19 | |
Graham number | 0 | 6.45 | 3.15 | 1.88 | 2.1 | |
ROIC | 0.78 | 0.18 | -1.07 | -0.23 | -0.79 | |
Return on tangible assets | -9.88 | -2.45 | -1.13 | -0.23 | -0.74 | |
Graham Net | 0 | -3.66 | -0.82 | 0.46 | -0.03 | |
Working capital | -57.07K | -15.33M | -8.46M | 39.36M | 8.75M | |
Tangible asset value | -57.07K | -124.89M | -22.24M | 29.56M | 18.22M | |
Net current asset value | -57.07K | -127.16M | -23.86M | 27.36M | 5.85M | |
Invested capital | 0 | -0.34 | -1.79 | 0.39 | 0.77 | |
Average receivables | 0 | 354.5K | 776.5K | 1.74M | 3.51M | |
Average payables | 0 | 1.19M | 2.78M | 3.4M | 5.76M | |
Average inventory | 0 | 495K | 1.31M | 3.98M | 7.37M | |
Days sales outstanding | 0 | 21.68 | 27.09 | 39.95 | 97.18 | |
Days payables outstanding | 0 | 133.98 | 173.81 | 105.63 | 165.03 | |
Days of inventory on hand | 0 | 55.66 | 88.87 | 184.39 | 175.72 | |
Receivables turnover | 0 | 16.83 | 13.47 | 9.14 | 3.76 | |
Payables turnover | 0 | 2.72 | 2.1 | 3.46 | 2.21 | |
Inventory turnover | 0 | 6.56 | 4.11 | 1.98 | 2.08 | |
ROE | 0.78 | 0.15 | 1.13 | -0.34 | -1.62 | |
Capex per share | 0 | -0.01 | 0 | -0.02 | -0.12 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.06 | 0.08 | 0.06 | 0.1 | 0.08 | |
Net income per share | -0.11 | -0.19 | -0.16 | -0.13 | -0.12 | |
Operating cash flow per share | -0.09 | -0.15 | -0.14 | -0.15 | -0.07 | |
Free cash flow per share | -0.14 | -0.18 | -0.16 | -0.15 | -0.08 | |
Cash per share | 0.59 | 0.41 | 0.27 | 0.06 | 0.1 | |
Book value per share | 0.64 | 0.5 | 0.34 | 0.39 | 0.39 | |
Tangible book value per share | 0.62 | 0.47 | 0.32 | 0.36 | 0.37 | |
Share holders equity per share | 0.64 | 0.5 | 0.34 | 0.39 | 0.39 | |
Interest debt per share | 0.27 | 0.27 | 0.27 | 0.05 | 0.05 | |
Market cap | 284.8M | 308.66M | 228.01M | 201.5M | 135.73M | |
Enterprise value | 266.64M | 300.72M | 227.55M | 201.1M | 132.36M | |
P/E ratio | -10.97 | -7 | -6.29 | -6.76 | -4.76 | |
Price to sales ratio | 77.6 | 68.7 | 71.43 | 34.25 | 27.09 | |
POCF ratio | -58.12 | -35.2 | -28.76 | -22.97 | -33.05 | |
PFCF ratio | -34.72 | -29.75 | -24.7 | -22.97 | -28.9 | |
P/B Ratio | 7.84 | 10.95 | 11.62 | 8.83 | 5.73 | |
PTB ratio | 7.84 | 10.95 | 11.62 | 8.83 | 5.73 | |
EV to sales | 72.65 | 66.93 | 71.29 | 34.18 | 26.42 | |
Enterprise value over EBITDA | -45.88 | -30.43 | -27.68 | -28.57 | -19.91 | |
EV to operating cash flow | -54.42 | -34.29 | -28.71 | -22.92 | -32.23 | |
EV to free cash flow | -32.5 | -28.98 | -24.65 | -22.92 | -28.18 | |
Earnings yield | -0.02 | -0.04 | -0.04 | -0.04 | -0.05 | |
Free cash flow yield | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 | |
Debt to equity | 0.42 | 0.54 | 0.77 | 0.13 | 0.12 | |
Debt to assets | 0.26 | 0.31 | 0.34 | 0.09 | 0.08 | |
Net debt to EBITDA | 3.13 | 0.8 | 0.06 | 0.06 | 0.51 | |
Current ratio | 2.48 | 1.98 | 1.4 | 2.45 | 2.63 | |
Interest coverage | -29.9 | -53.79 | -46.35 | -847.38 | 0 | |
Income quality | 0.82 | 0.84 | 0.9 | 1.18 | 0.58 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.83 | 0.77 | 1.21 | 0.77 | 0.59 | |
Research and developement to revenue | 0.5 | 0.52 | 0.94 | 0.49 | 0.6 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | |
Capex to operating cash flow | 0.67 | 0.18 | 0.16 | 0 | 0.14 | |
Capex to revenue | -0.9 | -0.36 | -0.41 | 0 | -0.12 | |
Capex to depreciation | -8.81 | -4.09 | -3.34 | 0 | -1.23 | |
Stock based compensation to revenue | 0.17 | 0.25 | 0.27 | 0.34 | 0.18 | |
Graham number | 1.29 | 1.47 | 1.11 | 1.04 | 1.01 | |
ROIC | -0.11 | -0.22 | -0.23 | -0.22 | -0.2 | |
Return on tangible assets | -0.11 | -0.23 | -0.21 | -0.23 | -0.22 | |
Graham Net | 0.31 | 0.15 | -0.03 | 0.03 | 0.06 | |
Working capital | 27.85M | 18.01M | 8.75M | 12.02M | 13.59M | |
Tangible asset value | 34.88M | 26.69M | 18.22M | 21.58M | 22.56M | |
Net current asset value | 25.04M | 15.34M | 5.85M | 9.4M | 11.33M | |
Invested capital | 0.42 | 0.54 | 0.77 | 0.13 | 0.12 | |
Average receivables | 2.41M | 2.66M | 4.05M | 5.66M | 5.74M | |
Average payables | 4.58M | 4.25M | 5.96M | 5.85M | 5M | |
Average inventory | 7.96M | 8.22M | 7.94M | 8.65M | 9.33M | |
Days sales outstanding | 39.65 | 74.2 | 123.95 | 105.79 | 82.11 | |
Days payables outstanding | 125.09 | 50.47 | 235.52 | 90.14 | 145.42 | |
Days of inventory on hand | 249.67 | 93.95 | 250.76 | 210.71 | 229.36 | |
Receivables turnover | 2.27 | 1.21 | 0.73 | 0.85 | 1.1 | |
Payables turnover | 0.72 | 1.78 | 0.38 | 1 | 0.62 | |
Inventory turnover | 0.36 | 0.96 | 0.36 | 0.43 | 0.39 | |
ROE | -0.18 | -0.39 | -0.46 | -0.33 | -0.3 | |
Capex per share | -0.06 | -0.03 | -0.02 | 0 | -0.01 |
TGAN Frequently Asked Questions
What is Transphorm, Inc. stock symbol ?
Transphorm, Inc. is a US stock , located in Goleta of Ca and trading under the symbol TGAN
What is Transphorm, Inc. stock quote today ?
Transphorm, Inc. stock price is $4.9 today.
Is Transphorm, Inc. stock public?
Yes, Transphorm, Inc. is a publicly traded company.